Modeling Single and Repeated Dose Pharmacokinetics of PFOA in Mice

2007, Perfluorooctanoic acid (PFOA)-induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha (PPARα), Toxicol. Sci., 98, 571, 10.1093/toxsci/kfm110

1974, A new look at the statistical model identification, IEEE Trans. Automat. Contr., 19, 716, 10.1109/TAC.1974.1100705

2008, Perfluoroalkyl acids and related chemistries—Toxicokinetics and modes of action, Toxicol. Sci., 102, 3, 10.1093/toxsci/kfm270

2006, Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys—Probing the determinants of long plasma half-lives, Toxicology, 227, 156, 10.1016/j.tox.2006.08.004

1992, Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice, Am. J. Physiol., 263, R728

2007, Perfluoroalkyl acids: what is the evidence telling us?, Environ. Health Perspect., 115, A250, 10.1289/ehp.115-a250

2001, Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats, Toxicol. Sci., 60, 44, 10.1093/toxsci/60.1.44

2004, Characterization of risk for general population exposure to perfluorooctanoate, Regul. Toxicol. Pharmacol., 39, 363, 10.1016/j.yrtph.2004.03.003

2007, Polyfluoroalkyl chemicals in the U.S. population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000, Environ. Health Perspect., 115, 1596, 10.1289/ehp.10598

2008, Critical role of PPAR{alpha} in perfluorooctanoic acid- and perfluorodecanoic acid-induced down-regulation of Oatp uptake transporters in mouse livers, Toxicol. Sci., 106, 37, 10.1093/toxsci/kfn161

1992, Induction of Leydig cell adenomas by ammonium perfluorooctanoate: A possible endocrine-related mechanism, Toxicol. Appl. Pharmacol., 113, 209, 10.1016/0041-008X(92)90116-A

2006, Perfluorooctanesulfonate and periluorooctanoate in red panda and giant panda from China, Environ. Sci. Technol., 40, 5647, 10.1021/es0609710

2007, Automatic numerical differentiation, MatlabCentral

2008, Increasing perfluoroalkyl contaminants in east Greenland polar bears (Ursus maritimus): A new toxic threat to the Arctic bears, Environ. Sci. Technol., 42, 2701, 10.1021/es7025938

2008, Uptake of perfluorooctanoate in freshly isolated hepatocytes from male and female rats, Toxicol. Lett., 181, 81, 10.1016/j.toxlet.2008.07.002

2005, Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion, Environ. Res., 99, 253, 10.1016/j.envres.2004.12.003

2001, Compound-Specific, Quantitative Characterization of Organic Fluorochemicals in Biological Matrices, Environ. Sci. Technol., 35, 779

2008, Comparing single and repeated dosimetry data for perfluorooctane sulfonate in rats, Toxicol. Lett., 181, 148, 10.1016/j.toxlet.2008.07.014

2004, The toxicology of perfluorooctanate, Crit. Rev. Toxicol., 34, 351, 10.1080/10408440490464705

2002, Sex hormone-regulated renal transport of perfluorooctanoic acid, Chem. Biol. Interact., 139, 301, 10.1016/S0009-2797(02)00006-6

2003, Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals, J. Toxicol. Sci., 28, 49, 10.2131/jts.28.49

2007, Tissue distribution and hepatic subcellular distribution of perfluorooctanoic acid at low dose are different from those at high dose in rats, Biol. Pharm. Bull., 30, 1535, 10.1248/bpb.30.1535

1998, Convergence properties of the Nelder-Mead Simplex Method in Low Dimensions, SIAM J. Optim., 9, 112, 10.1137/S1052623496303470

2007, Perfluoroalkyl acids: A review of monitoring and toxicological findings, Toxicol. Sci., 99, 366, 10.1093/toxsci/kfm128

2006, Effects of perfluorooctanoic acid exposure during pregnancy in the mouse, Toxicol. Sci., 90, 510, 10.1093/toxsci/kfj105

1990, Nonlinear mixed effects models for repeated measures data, Biometrics, 46, 673, 10.2307/2532087

2002, Age dependency of renal function in CD-1 mice, Am. J. Physiol. Renal Physiol., 282, 886, 10.1152/ajprenal.00134.2001

2008, Nrf2 and PPAR{alpha}-Mediated Regulation of Hepatic Mrp Transporters after Exposure to Perfluorooctanoic Acid and Perfluorodecanoic Acid, Toxicol. Sci, 106, 319, 10.1093/toxsci/kfn177

2008, Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid, Basic Clin. Pharmacol. Toxicol., 103, 1, 10.1111/j.1742-7843.2007.00155.x

2007, Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluooctanoate in retired fluorochemical production workers, Environ. Health Perspect., 115, 1298, 10.1289/ehp.10009

2000, Mixed-Effects Models in S and S-PLUS

2007, Nlme: Linear and Nonlinear Mixed Effects Models. R package version 3, 1

2004, Serial determination of glomerular filtration rate in conscious mice using FITC-insulin clearance, Am. J. Physiol. Renal Physiol., 286, 509

R Development Core Team, 2007

1997, The Matlab ODE suite, SIAM J. Sci. Comput., 18, 1, 10.1137/S1064827594276424

2008, Time dependencies in perfluorooctylacids disposition in rat and monkeys: A kinetic analysis, Toxicol. Lett., 177, 38, 10.1016/j.toxlet.2007.12.007

2008, Estimating consumer exposure to PFOS and PFOA, Risk Anal., 28, 251, 10.1111/j.1539-6924.2008.01017.x

U.S. EPA, 2005, Draft risk assessment of the potential human health effects associated with exposure to perfluorooctanoic acid and its salts (PFOA). OPPT, Washington, DC

2005, Exposure assessment and risk characterization for perfluorooctanoate in selected consumer articles, Environ. Sci. Technol., 39, 3904, 10.1021/es048353b

2007, Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring, Toxicol. Sci., 96, 133

2007, Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposure, Toxicol. Sci., 95, 461